Absci (ABSI) Receivables - Net (2020 - 2026)

Absci (ABSI) reported Receivables - Net of $100000.0 for Q1 2026, down 92.77% on a YoY basis from $1.4 million in Q1 2025, and down 90.0% sequentially from $1.0 million in Q3 2025.

Absci (ABSI) Receivables - Net (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Receivables - Net data on file, last reported at $100000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Receivables - Net fell 92.77% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $100000.0 (down 92.77% YoY), and the FY2023 full-year result was $2.2 million, up 41.23% from the prior year.
  • Receivables - Net slipped to $100000.0 in Q1 2026, from $1.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $3.2 million in Q2 2023 to a low of $42000.0 in Q1 2024.
  • A 5-year average of $977466.7 and a median of $800000.0 in 2023 frame the typical range for Receivables - Net.
  • Across the five-year window, Receivables - Net sank 98.61% in 2024 and surged 3195.24% in 2025, its largest moves.
  • Tracing ABSI's Receivables - Net over 5 years: stood at $1.5 million in 2022, then jumped by 41.23% to $2.2 million in 2023, then sank by 31.48% to $1.5 million in 2024, then sank by 33.33% to $1.0 million in 2025, then slumped by 90.0% to $100000.0 in 2026.
  • Business Quant data shows ABSI's Receivables - Net at $100000.0 in Q1 2026, $1.0 million in Q3 2025, and $700000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Absci 1.23 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Mar 31, 2026 100,000.00
Sep 30, 2025 1.00 Mn
Sep 30, 2025 1.00 Mn
Jun 30, 2025 700,000.00
Jun 30, 2025 700,000.00
Mar 31, 2025 1.38 Mn
Mar 31, 2025 1.38 Mn
Sep 30, 2024 1.50 Mn
Sep 30, 2024 1.50 Mn
Jun 30, 2024 44,000.00
Jun 30, 2024 44,000.00
Mar 31, 2024 42,000.00
Mar 31, 2024 42,000.00
Dec 31, 2023 2.19 Mn
Dec 31, 2023 2.19 Mn
Sep 30, 2023 800,000.00
Sep 30, 2023 800,000.00
Jun 30, 2023 3.16 Mn
Jun 30, 2023 3.16 Mn